These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 12767468

  • 1. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
    Andersen JH, Jenssen H, Gutteberg TJ.
    Antiviral Res; 2003 May; 58(3):209-15. PubMed ID: 12767468
    [Abstract] [Full Text] [Related]

  • 2. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
    Andersen JH, Jenssen H, Sandvik K, Gutteberg TJ.
    J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
    [Abstract] [Full Text] [Related]

  • 3. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y, Raj KM, Luscombe CA, Gadawski I, Tam T, Chu J, Gibson D, Carlson R, Sacks SL.
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
    Marr AK, Jenssen H, Moniri MR, Hancock RE, Panté N.
    Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
    [Abstract] [Full Text] [Related]

  • 6. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate.
    Jenssen H, Andersen JH, Uhlin-Hansen L, Gutteberg TJ, Rekdal Ø.
    Antiviral Res; 2004 Feb; 61(2):101-9. PubMed ID: 14670583
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
    Jenssen H, Sandvik K, Andersen JH, Hancock RE, Gutteberg TJ.
    Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
    [Abstract] [Full Text] [Related]

  • 8. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O, Barbani MT, Klenja S, Morfin F, Frobert E, Gorgievski M, Steinlin-Schopfer J, Suter-Riniker F.
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [Abstract] [Full Text] [Related]

  • 10. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.
    Danve C, Morfin F, Thouvenot D, Aymard M.
    J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654
    [Abstract] [Full Text] [Related]

  • 11. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
    Marcelletti JF.
    Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
    [Abstract] [Full Text] [Related]

  • 12. Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus.
    Mucsi I, Molnár J, Motohashi N.
    Int J Antimicrob Agents; 2001 Jul; 18(1):67-72. PubMed ID: 11463529
    [Abstract] [Full Text] [Related]

  • 13. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
    Thompson KD.
    Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
    [Abstract] [Full Text] [Related]

  • 14. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX, Takayama-Ito M, Kinoshita-Yamaguchi H, Kakiuchi S, Suzutani T, Nakamichi K, Lim CK, Kurane I, Saijo M.
    Jpn J Infect Dis; 2013 Jul; 66(5):404-10. PubMed ID: 24047739
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
    Priengprom T, Ekalaksananan T, Kongyingyoes B, Suebsasana S, Aromdee C, Pientong C.
    BMC Complement Altern Med; 2015 Mar 11; 15():56. PubMed ID: 25879785
    [Abstract] [Full Text] [Related]

  • 16. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, O'Leary Bartus J, Van Horn MM, Sathe GM, Van Horn S, Kelly MD, Bacon TH, Leary JJ.
    J Virol; 2001 Feb 11; 75(4):1761-9. PubMed ID: 11160674
    [Abstract] [Full Text] [Related]

  • 17. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
    Saijo M, Suzutani T, De Clercq E, Niikura M, Maeda A, Morikawa S, Kurane I.
    Antiviral Res; 2002 Dec 11; 56(3):253-62. PubMed ID: 12406508
    [Abstract] [Full Text] [Related]

  • 18. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H.
    Antiviral Res; 2006 Mar 11; 69(3):152-7. PubMed ID: 16388859
    [Abstract] [Full Text] [Related]

  • 19. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A, Reichling J, Schnitzler P.
    Phytomedicine; 2003 Mar 11; 10(6-7):504-10. PubMed ID: 13678235
    [Abstract] [Full Text] [Related]

  • 20. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M, van de Vijver DA, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM.
    J Infect Dis; 2013 Nov 01; 208(9):1359-65. PubMed ID: 23901090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.